Jun Hino Selected Research

Jun Hino Research Topics

Disease

4	Inflammation (Inflammations) 01/2020 - 01/2017
4	Obesity 09/2018 - 01/2017
3	Fibrosis (Cirrhosis) 10/2022 - 09/2018
3	Neoplasms (Cancer) 01/2022 - 01/2017
3	Cardiomegaly (Heart Hypertrophy) 01/2020 - 04/2005
3	Insulin Resistance 09/2018 - 01/2017
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2017 - 02/2016
2	Alcoholic Fatty Liver 09/2018 - 01/2018
2	Infarction (Infarctions) 01/2018 - 01/2004
2	Ischemia 01/2018 - 01/2004
2	Body Weight (Weight, Body) 01/2018 - 05/2008
2	Heart Failure 01/2017 - 01/2004
1	Sarcopenia 01/2021
1	Atrophy 01/2021
1	Muscle Weakness 01/2021
1	Left Ventricular Dysfunction 01/2020
1	Cardiomyopathies (Cardiomyopathy) 01/2020
1	Liver Diseases (Liver Disease) 09/2018
1	Dyslipidemias (Dyslipidemia) 09/2018
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2018
1	Cerebral Palsy (Spastic Diplegia) 01/2018
1	Brain Injuries (Brain Injury) 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Hypertrophy 01/2018
1	Intellectual Disability (Idiocy) 01/2018
1	Neoplasm Metastasis (Metastasis) 09/2017
1	Cerebral Cavernous Malformations 2 01/2017
1	Agranulocytosis (Granulocytopenia) 01/2017
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2017
1	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2016
1	Lung Neoplasms (Lung Cancer) 02/2016
1	Myocardial Infarction 01/2004
1	Reperfusion Injury 01/2004
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2004
1	African Trypanosomiasis (Nagana) 09/2003
1	Pulmonary Hypertension 08/2003
1	Genetic Predisposition to Disease (Genetic Predisposition) 06/2003
1	Glomerulonephritis 06/2003
1	Type 2 Diabetes Mellitus (MODY) 06/2003
1	Renal Insufficiency (Renal Failure) 06/2003
1	Atrial Fibrillation 01/2002

Drug/Important Bio-Agent (IBA)

6	Atrial Natriuretic Factor (ANF)IBA 01/2022 - 01/2002
6	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 09/2018 - 02/2016
3	Glucose (Dextrose)FDA LinkGeneric 09/2018 - 01/2017
3	AdrenomedullinIBA 04/2005 - 06/2003
2	Natriuretic PeptidesIBA 01/2020 - 05/2008
2	Insulin (Novolin)FDA Link 09/2018 - 01/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 09/2018 - 01/2018
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2017 - 02/2016
2	CollagenIBA 02/2016 - 01/2002
2	DNA (Deoxyribonucleic Acid)IBA 08/2003 - 06/2003
1	Silicon Dioxide (Silica)FDA LinkGeneric 10/2022
1	Phosphotransferases (Kinase)IBA 01/2020
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2020
1	AldosteroneIBA 01/2020
1	CDAA (Randox)IBA 09/2018
1	asparagine-oxo-acid aminotransferaseIBA 09/2018
1	AcidsIBA 09/2018
1	Choline (Choline Chloride)IBA 09/2018
1	CholesterolIBA 09/2018
1	LipidsIBA 09/2018
1	Blood Glucose (Blood Sugar)IBA 09/2018
1	Triglycerides (Triacylglycerol)IBA 09/2018
1	NeuropeptidesIBA 01/2018
1	neuromedin UIBA 01/2018
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2018
1	Growth Differentiation Factor 10IBA 01/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	Hormones (Hormone)IBA 09/2017
1	RNA (Ribonucleic Acid)IBA 09/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	p21-Activated KinasesIBA 01/2017
1	InterleukinsIBA 02/2016
1	Messenger RNA (mRNA)IBA 02/2016
1	Interleukin-6 (Interleukin 6)IBA 02/2016
1	CytokinesIBA 02/2016
1	atrial natriuretic factor receptor AIBA 05/2008
1	CalcineurinIBA 05/2008
1	Adrenomedullin ReceptorsIBA 04/2005
1	WortmanninIBA 01/2004
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2004
1	COOH-terminal signal transamidaseIBA 09/2003
1	Vasodilator Agents (Vasodilators)IBA 08/2003
1	MonocrotalineIBA 08/2003
1	Biomarkers (Surrogate Marker)IBA 01/2002

Therapy/Procedure

1	Denervation 01/2021
1	Glycemic Control 09/2018
1	Therapeutics 02/2016
1	Ligation 01/2004
1	Intravenous Administration 01/2004
1	Transplantation 08/2003
1	Renal Dialysis (Hemodialysis) 06/2003
1	Maze Procedure 01/2002